Topical cannabinoid enhances topical morphine antinociception.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 14499448)

Published in Pain on September 01, 2003

Authors

Ozgur Yesilyurt1, Ahmet Dogrul, Husamettin Gul, Melik Seyrek, Ozkan Kusmez, Yalcin Ozkan, Oguzhan Yildiz

Author Affiliations

1: Department of Pharmacology, School of Medicine, Gulhane Military Medical Academy, 06018 Etlik, Ankara, Turkey. oyesilyurt@gata.edu.tr

Articles citing this

Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol (2009) 2.23

The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc Natl Acad Sci U S A (2006) 1.39

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev (2008) 1.28

Endocannabinoid mechanisms of pain modulation. AAPS J (2006) 1.28

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci (2012) 1.27

The analgesic potential of cannabinoids. J Opioid Manag (2010) 1.16

Harm reduction--the cannabis paradox. Harm Reduct J (2005) 0.94

Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. Neuropharmacology (2009) 0.88

High concentrations of morphine sensitize and activate mouse dorsal root ganglia via TRPV1 and TRPA1 receptors. Mol Pain (2009) 0.87

[Cannabinoids--signal transduction and mode of action]. Schmerz (2005) 0.87

Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception. Neuropharmacology (2008) 0.85

Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems. Pain Ther (2015) 0.81

Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain. Br J Pharmacol (2009) 0.80

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis. Neuropsychopharmacology (2017) 0.75

The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain. Neuroscience (2013) 0.75

Articles by these authors

Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation. Eur J Pharm Biopharm (2011) 1.04

The histopathologic, pharmacologic and urodynamic results of mesenchymal stem cell's injection into the decompensated rabbit's bladder. Stem Cell Rev (2012) 1.03

5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice. Pharmacol Biochem Behav (2012) 0.95

The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac. Anesth Analg (2006) 0.94

In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug Deliv (2007) 0.93

Protective efficiacy of taurine against pulmonary edema progression: experimental study. J Cardiothorac Surg (2008) 0.93

Testosterone relaxes isolated human radial artery by potassium channel opening action. J Pharmacol Sci (2007) 0.92

Topical cannabinoid antinociception: synergy with spinal sites. Pain (2003) 0.91

Dexmedetomidine produces dual alpha2-adrenergic agonist and alpha1-adrenergic antagonist actions on human isolated internal mammary artery. J Cardiothorac Vasc Anesth (2007) 0.90

Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic pathways. Anesthesiology (2010) 0.90

Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats. J Gastroenterol (2004) 0.90

Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice. Acta Diabetol (2010) 0.89

In vitro and ex vivo permeation studies of chlorpheniramine maleate gels prepared by carbomer derivatives. Drug Dev Ind Pharm (2004) 0.86

Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy. J Gastroenterol Hepatol (2007) 0.85

Testosterone might cause relaxation of human corpus cavernosum by potassium channel opening action. Urology (2009) 0.85

Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation. Eur J Pharm Biopharm (2006) 0.83

Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS. ScientificWorldJournal (2012) 0.83

The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test. Anesth Analg (2007) 0.83

Testosterone relaxes human internal mammary artery in vitro. J Cardiovasc Pharmacol (2005) 0.83

Renal tubular dysfunction in beta-thalassemia minor. Am J Kidney Dis (2003) 0.82

The involvement of nitric oxide in the analgesic effects of ketamine. Life Sci (2002) 0.82

Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT₇ receptors. Eur J Pharmacol (2011) 0.82

Pharmacologic characterization of contractile serotonergic receptors in human isolated mesenteric artery. J Cardiovasc Pharmacol (2003) 0.82

Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors. Eur J Pharmacol (2010) 0.81

Interaction between dexmedetomidine and α-adrenergic receptors: emphasis on vascular actions. J Cardiothorac Vasc Anesth (2011) 0.81

Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.80

Potassium channels in the vasodilating action of levosimendan on the human umbilical artery. J Soc Gynecol Investig (2006) 0.80

Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity. Interdiscip Toxicol (2009) 0.80

The efficiency of proanthocyanidin in an experimental pulmonary fibrosis model: comparison with taurine. Inflammation (2012) 0.80

Inflammation and peripheral 5-HT7 receptors: the role of 5-HT7 receptors in carrageenan induced inflammation in rats. Eur J Pharmacol (2013) 0.80

Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice. Neurosci Lett (2004) 0.78

The effect of intravesical acetylsalicylic acid instillation on tissue prostaglandin levels after partial bladder outlet obstruction in rabbits. Neurourol Urodyn (2011) 0.77

Testosterone relaxes human internal spermatic vein through potassium channel opening action. Urology (2011) 0.77

Detection of PIGO-deficient cells using proaerolysin: a valuable tool to investigate mechanisms of mutagenesis in the DT40 cell system. PLoS One (2012) 0.77

Clopidogrel resistance: a diagnostic challenge. Int J Cardiol (2007) 0.77

Increased vasoconstrictor reactivity and decreased endothelial function in high grade varicocele; functional and morphological study. Urol Res (2003) 0.77

Amplification of sumatriptan-induced contractions with phenylephrine, histamine and KCl in the isolated human mesenteric artery: in-vitro evidence for sumatriptan-induced mesenteric ischaemia. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.77

Lipophilic components of different therapeutic mud species. J Altern Complement Med (2007) 0.77

The effect of hepatectomy on coagulation: an evaluation by thromboelastography. Eur J Gastroenterol Hepatol (2010) 0.76

Potassium channel-related relaxation by levosimendan in the human internal mammary artery. Ann Thorac Surg (2006) 0.76

Formation of hydroxymethyl DNA adducts in rats orally exposed to stable isotope labeled methanol. Toxicol Sci (2011) 0.76

The development and in vitro evaluation of sustained release tablet formulations of benzydamine hydrochloride and its determination. Comb Chem High Throughput Screen (2010) 0.76

Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation. Drug Deliv (2009) 0.76

The effect of mineral trioxide aggregate on the contractility of the rat thoracic aorta. J Endod (2007) 0.75

Investigation of vasoactive ion content of herbs used in hemorrhoid treatment in Turkey. Pak J Pharm Sci (2009) 0.75

Vasodilatory effect of hydroxyethyl methacrylate and triethylene glycol dimethacrylate in rat aorta through calcium antagonistic action. J Endod (2011) 0.75

Vasocontractile effect of SeraSeal in rat thoracic aorta. Saudi Med J (2010) 0.75

Pentoxifylline response in alloxan-induced diabetic rats. Acta Otolaryngol (2008) 0.75

Vasorelaxant effects of Clearfil SE Bond and Clearfil S(3) Bond mediated by calcium antagonistic action. J Biomater Sci Polym Ed (2010) 0.75

The vasodilator effect of testosterone on the human internal spermatic vein and its relation to varicocele grade. J Urol (2008) 0.75

Effect of colored beverages on the color stability of feldspathic porcelain subjected to various surface treatments. Quintessence Int (2009) 0.75

Influence of estradiol pretreatment on antimuscarinic action of oxybutynin in rat detrusor muscle. Urology (2005) 0.75

Elevated serum neopterin levels in acetaminophen-induced liver injury. Environ Toxicol Pharmacol (2010) 0.75

The relationship between risk factors and testosterone-induced relaxations in human internal mammary artery. J Cardiovasc Pharmacol (2005) 0.75

The concentration-dependent contractile effect of methylene blue in the human internal mammary artery: a quantitative approach to its use in the vasoplegic syndrome. J Cardiothorac Vasc Anesth (2008) 0.75

Vasorelaxant effect of a self-etch adhesive system through calcium antagonistic action. J Endod (2008) 0.75